Knowing what we do not know: statin therapy in advanced chronic kidney disease Muh Geot Wong, Vlado Perkovic The Lancet Diabetes & Endocrinology Volume 4, Issue 10, Pages 801-803 (October 2016) DOI: 10.1016/S2213-8587(16)30192-9 Copyright © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC-BY-NC-ND license Terms and Conditions
Figure Cardiovascular event rates prevented (absolute difference between randomised groups) and not prevented (residual event rates in the statin arm) in the SHARP trial,6 according to baseline renal function The Lancet Diabetes & Endocrinology 2016 4, 801-803DOI: (10.1016/S2213-8587(16)30192-9) Copyright © 2016 The Author(s). Published by Elsevier Ltd. This is an Open Access article under the CC-BY-NC-ND license Terms and Conditions